Diagnóstico precoz de la infección congénita por citomegalovirus: oportunidades perdidas. [artículo]
Por: Becerril Morencos, Jesús [Pediatría]
| Blázquez Gamero, Daniel [Pediatría] | Nuñez Ramos, Raquel [Pediatría] | Rojo Conejo, Pablo [Pediatría].
Colaborador(es): Servicio de Pediatría-Neonatología.
Editor: Enfermedades infecciosas y microbiología clínica, 2013Descripción: 31(2):93-6.Recursos en línea: Solicitar documento Resumen: Cytomegalovirus (CMV) infection is the most common congenital infection in Europe. Symptoms are present at birth in 10% of infected children, and up to 30-40% have some degree of hearing loss after the newborn period. Methods: A retrospective study was performed over a period of 4 years and included all patients with congenital CMV infection diagnosed after the neonatal period using the dried blood spots from neonatal metabolic screening. Results: We present 5 patients diagnosed with congenital CMV infection outside the neonatal period. The main reasons for consultation were hearing loss and/or neurological impairment in the first few months of life. Discussion: Congenital CMV infection may be mildly symptomatic at birth, and present as hearing loss and/or neurological impairment in infancy. Therefore, a high degree of suspicion is necessary in order to make an accurate diagnosis and start specific treatment to improve the outcome.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Artículo
|
PC2889 (Navegar estantería) | Disponible |
Formato Vancouver:
Nuñez-Ramos R, Becerril J, Blázquez D, Rojo P, de Vergas J, Folgueira D. Grupo de Estudio del CMVc del Hospital 12 de Octubre. Diagnóstico precoz de la infección congénita por citomegalovirus: oportunidades perdidas. Enferm Infecc Microbiol Clin. 2013 Feb;31(2):93-6.
PMID: 22902268
Contiene 10 referencias
Cytomegalovirus (CMV) infection is the most common congenital infection in Europe. Symptoms are present at birth in 10% of infected children, and up to 30-40% have some degree of hearing loss after the newborn period. Methods: A retrospective study was performed over a period of 4 years and included all patients with congenital CMV infection diagnosed after the neonatal period using the dried blood spots from neonatal metabolic screening. Results: We present 5 patients diagnosed with congenital CMV infection outside the neonatal period. The main reasons for consultation were hearing loss and/or neurological impairment in the first few months of life. Discussion: Congenital CMV infection may be mildly symptomatic at birth, and present as hearing loss and/or neurological impairment in infancy. Therefore, a high degree of suspicion is necessary in order to make an accurate diagnosis and start specific treatment to improve the outcome.
No hay comentarios para este ejemplar.